ArticleClinical Medicine Insights. Oncology2023

The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients.

Yuqin Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.